PrP made by glia can theoretically contribute to a natural prion disease process as demonstrated by the finding that transgenic mice expressing PrP directed by a glial fibrillary acidic protein (GFAP) promoter are vulnerable to prion infection [21]. The gene discussed is PRNP; the disease is prion disease.